Administration, Intravaginal < Administration, Oral < Administration, Sublingual

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]

Ident.	Authors (with country if any)	Title
000C58 (2012)	Raffaella Zannolli [Italie] ; Sabrina Buoni ; Gianni Betti ; Sara Salvucci ; Alessandro Plebani ; Annarosa Soresina ; Maria C. Pietrogrande ; Silvana Martino ; Vincenzo Leuzzi ; Andrea Finocchi ; Roberto Micheli ; Livia Nicoletta Rossi ; Alfredo Brusco ; Filippo Misiani ; Alberto Fois ; Joseph Hayek ; Colleen Kelly ; Luciana Chessa	A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.
001528 (2010)	William G. Ondo [États-Unis] ; Lina Shinawi ; Steven Moore	Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
001675 (2010)	Fabrizio Stocchi [Italie] ; Mario Zappia ; Valentina Dall'Armi ; Jaime Kulisevsky ; Paolo Lamberti ; José Angel Obeso	Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.
001A27 (2010)	Maria Nord [Suède] ; Peter Zsigmond ; Anita Kullman ; Kerstin Arstrand ; Nil Dizdar	The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.
002167 (2008)	Jae Young An ; Joong-Seok Kim ; Yeong-In Kim ; Kwang Soo Lee	Successful treatment of the Meige syndrome with oral zolpidem monotherapy.
002459 (2008)	Birgit Meiler [Allemagne] ; Jürgen Andrich ; Thomas Müller	Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.
002806 (2007)	Regina Katzenschlager [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; Kim Stockwell ; Kayhan A. Tayarani-Binazir ; Mohammed Zubair ; Lance A. Smith ; Peter Jenner ; Andrew J. Lees	Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
002980 (2007)	Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano ; Manel Barbanoj ; Alexandre Gironell ; Javier Pagonabarraga ; Carmen García-Sánchez	Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
002B45 (2006)	J Antonelle Demarcaida [États-Unis] ; Steven R. Schwid ; William B. White ; Karen Blindauer ; Stanley Fahn ; Karl Kieburtz ; Matthew Stern ; Ira Shoulson	Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
002C17 (2006)	Angela Deutschl Nder [Allemagne] ; Friedrich Asmus ; Elena Marelli ; Thomas Klopstock ; Thomas Gasser ; Kai Bötzel	Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
002C29 (2006)	Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen ; Jens Carsten Möller ; Claudia Trenkwalder ; Wolfgang H. Oertel	Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
002D08 (2006)	Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández ; Vesna Sossi ; Michael Schulzer ; Lakshmi N. Yatham ; Thomas J. Ruth ; Stephan Blinder ; A Jon Stoessl	Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
003327 (2004)	Lisa Jerome ; Rick Doblin ; Michael Mithoefer	Ecstasy use-Parkinson's disease link tenuous.
003B17 (2002)	Padraig O'Suilleabhain [États-Unis] ; Richard B. Dewey	Randomized trial comparing primidone initiation schedules for treating essential tremor.
003B30 (2002)	Ruth Djaldetti [Israël] ; Rivkah Inzelberg ; Nir Giladi ; Amos D. Korczyn ; Yehudit Peretz-Aharon ; Martin J. Rabey ; Yuval Herishano ; Silvia Honigman ; Sami Badarny ; Eldad Melamed	Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.
003D03 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Y. Agid	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
003F14 (2000)	I. Reuter [Royaume-Uni] ; S. Harder ; M. Engelhardt ; H. Baas	The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa.
004013 (2000)	A J Manson [Royaume-Uni] ; E. Iakovidou ; A J Lees	Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease.
004150 (1999)	R K Pearce [Royaume-Uni]	L-dopa and dyskinesias in normal monkeys.
004308 (1998)	S. Ohara [Japon] ; R. Hayashi ; H. Momoi ; J. Miki ; N. Yanagisawa	Mexiletine in the treatment of spasmodic torticollis.
004339 (1998)	E J Skalabrin [États-Unis] ; E R Laws ; J P Bennett	Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Administration, Oral" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Administration, Oral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Administration, Oral
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024